Gaurav is a strategic and tactical operations leader, with a wealth of experience building and managing high-performing teams and developing innovative, creative and quality-driven solutions for clients. Gaurav brings strong and varied therapeutic expertise and strategic leadership skills, developed across franchise areas within several CROs and now to Worldwide. Prior to joining Worldwide, Gaurav was a Senior Vice President and Head of Global Project Management with Premier Research.
Gaurav has worked extensively in Solid Tumor and Hematological Malignancies. More recently, Gaurav was responsible for overall successful delivery of clinical programs involving Immune Checkpoint Inhibitor for the treatment of solid tumors and hematological malignancies.
Gaurav was program director for large program with Tyrosine Kinase Inhibitor (TKI) involving several studies, including pivotal study for patients with EGFR mutated NSCLC; leading to marketing authorization.
Gaurav is a Project Management Institute (PMI) certified Project Management Professional, a Certified Director by the World Council for Corporate Governance and a Chartered Scientist (C.Sci) by the Science Council in the United Kingdom, with a wealth of experience working with pharmaceutical companies such as; Lundbeck, Allergan, Takeda and global CROs such as IQVIA, Parexel, Icon, Premier Research and ClinTec.